Temesgen Baylie

Mr. Temesgen Baylie


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2024 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
TBTemesgen Baylie
Temesgen Baylie
MKMulugeta Kasaw
Mulugeta Kasaw
MGMamaru Getinet
Mamaru Getinet
GGGedefaw Getie
Gedefaw Getie
MJMohammed Jemal
Mohammed Jemal
MBMihiret Bogale
Mihiret Bogale
Breast cancer (BC) is the second most common cause of deaths reported in women worldwide, and therefore there is a need to identify BC patients at an early stage as timely diagnosis would help in effective management and appropriate monitoring of patients. This will allow for proper patient monitoring and effective care. However, the absence of a particular biomarker for BC early diagnosis and surveillance makes it difficult to accomplish these objectives. miRNAs have been identified as master regulators of the molecular pathways that are emphasized in various tumors and that lead to the advancement of malignancies. Small, non-coding RNA molecules known as miRNAs target particular mRNAs to control the expression of genes. miRNAs dysregulation has been linked to the start and development of a number of human malignancies, including BC, since there is compelling evidence that miRNAs can function as tumor suppressor genes or oncogenes. The current level of knowledge on the role of miRNAs in BC diagnosis, prognosis, and treatment is presented in this review. miRNAs can regulate the tumorigenesis of BC through targeting PI3K pathway and can be used as prognostic or diagnostic biomarkers for BC therapy. Some miRNAs, like miR-9, miR-10b, and miR-17-5p, are becoming known as biomarkers of BC for diagnosis, prognosis, and therapeutic outcome prediction. Other miRNAs, like miR-30c, miR-187, and miR-339-5p, play significant roles in the regulation of hallmark functions of BC, including invasion, metastasis, proliferation, resting death, apoptosis, and genomic instability. Other miRNAs, such as miR-155 and miR-210, are circulating in bodily fluids and are therefore of interest as novel, conveniently accessible, reasonably priced, non-invasive methods for the customized care of patients with BC.

1 March 2024 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
TBTemesgen Baylie
Temesgen Baylie
TATiget Ayelgn
Tiget Ayelgn
MTMarkeshaw Tiruneh
Markeshaw Tiruneh
KTKibur Hunie Tesfa
Kibur Hunie Tesfa
Obesity is defined as an abnormal or excessive accumulation of fat that increases the burden of different chronic diseases in the population. It has reached epidemic proportions and is a major risk factor for a variety of diseases, including hypertension, cardiovascular disease, type 2 diabetes, dyslipidaemia, atherosclerosis, and some malignancies. Weight gain is a result of excessive energy intake compared to energy expenditure (energy loss from metabolism and physical exercise). A ketogenic diet has a more useful effect on obesity than other diets. A ketogenic diet is a low-carbohydrate, high-fat, moderate-protein diet that induces the production of ketone bodies by mimicking the breakdown of a fasting state. The mechanism behind the ketogenic diet is still unknown, although it obviously helps people with obesity lose weight. Several pathways for the ketogenic diet effect on weight loss have been hypothesized by researchers, including reduced appetite due to effects on appetite control hormones and a possible direct appetite suppressant action of ketone bodies; reduced lipogenesis and increased lipolysis; greater metabolic efficiency; and increased metabolic costs.

14 February 2025 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
TBTemesgen Baylie
Temesgen Baylie
MJMohammed Jemal
Mohammed Jemal
GBGelagay Baye
Gelagay Baye
MGMamaru Getinet
Mamaru Getinet
GAGashaw Azanaw Amare
Gashaw Azanaw Amare
DSDeresse Sinamaw
Deresse Sinamaw
Telomeres are dynamic complexes at the ends of chromosomes that are made up of protective proteins and tandem repeating DNA sequences. In the large majority of cancer cells, telomere length is maintained by telomerase, an enzyme that elongates telomeres. Telomerase activation is seen in the majority of cancer, which permits uncontrol cell proliferation. About 90% of human malignancies show telomere dysfunction and telomerase reactivation; as a result, telomerase activation plays a special role as a practically universal stage on the way to malignancy. This review understands the structural and functional of telomere and telomerase, mechanisms of telomerase activation in oncogenesis, biomarkers and therapeutic targets. Therapeutic strategies targeting telomerase, including antisense oligonucleotides, G-quadruplex stabilizers, immunotherapy, small-molecule inhibitors, gene therapy, Telomerase-Responsive Drug Release System, have shown promise in preclinical and clinical settings. Advances in telomere biology not only illuminate the complex interplay between telomeres, telomerase, and cancer progression but also open avenues for innovative, targeted cancer therapies.

1 October 2023 in Journal of Experimental Pharmacology
Verified
Journal Article
Open access
PDF file
TBTemesgen Baylie
Temesgen Baylie
AKAssefa Kebad
Assefa Kebad
TATiget Ayelgn
Tiget Ayelgn
MTMarkeshaw Tiruneh
Markeshaw Tiruneh
KTKibur Hunie Tesfa
Kibur Hunie Tesfa
Background: Managing diabetes mellitus with currently available drugs is costly, and the chances of side effects are high, leading to further studies for new and better medications from plant sources with the affordable and lower side effects. This study aimed to evaluate the anti-diabetic effects of Datura stramonium Linn (Solanaceae) Leaves Extract in Streptozotocin- Induced Diabetic Mice. Methods: Male Swiss albino mice were induced into diabetes using 150mg/kg of STZ. Mice were allocated randomly into six groups, five mice per group. Group I was a normal control, Group II was Diabetic negative control, group III was Diabetic positive control, Group IV–VI were Diabetic Mice that treated with extract (100, 200 and 400 mg/kg) for 14 days. The FBG measurements were done on 0, 7th, and 14th days of treatment. After 14th day of treatment the mice were anesthetized with diethyl ether. Then, blood was drawn by cardiac puncture to assess TC, TG, LDL-C, and HDL-C. The antioxidant activity of the extract was determined using a DPPH assay. The data were entered into Epi-Data version 4.6, exported to SPSS version 26.0, and analyzed using a one-way ANOVA followed by a Tukey post hoc test. P < 0.05 was considered statistically significant. Results: The extract of D. stramonium reduced the FBG level by 19.71%, 30.27%, 40.95%, and 45.67%, respectively, for D. stramonium 100, 200, 400, and GLC 5 mg/kg on the 14th day of treatment. Diabetic mice treated with D. stramonium for 14 days showed a significant decrease in serum TC, LDL, and serum TG and a significant increase in body weight, and HDL level as compared to diabetic negative control. Antioxidant activities of the leaves extract were comparable to ascorbic acid with an IC50 of 172.79 μg/mL. Conclusion: These findings revealed that the D. stramonium leaves extract possesses significant Anti-diabetic activities.

7 February 2026 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
TBTemesgen Baylie
Temesgen Baylie
EGEndalkachew Gugsa
Endalkachew Gugsa
MJMohammed Jemal
Mohammed Jemal
GBGelagay Baye
Gelagay Baye
MGMamaru Getinet
Mamaru Getinet
DSDeresse Sinamaw
Deresse Sinamaw
Unraveling complex mechanisms of telomere biology is central to understanding the close link between aging and inflammation. Telomeres are repetitive heterochromatin DNA structures at the ends of eukaryotic chromosomes, and their length is universally accepted as a marker of biological aging. Telomeres progressively shorten with every cell division until they ultimately trigger cellular senescence and apoptosis. Telomere shortening is also promoted by chronic inflammation and oxidative stress. Chronic inflammation and oxidative stress have been shown to be key drivers of age-related diseases, including neurodegeneration, cardiovascular disease, and cancer. Telomerase is central regulator at the intersection of genomic stability, mitochondrial function, epigenetic integrity, and proteostasis. Through its direct and indirect actions, telomerase modulates inflammatory pathways that drive aging and age-related diseases, highlighting its potential as a therapeutic target to mitigate inflammaging and extend healthspan.

1 January 2024 in AIDS Research and Treatment
Verified
Journal Article
Open access
MJMohammed Jemal
Mohammed Jemal
AAAdane Adugna
Adane Adugna
MGmamaru engda getinet
mamaru engda getinet
TBTemesgen Baylie
Temesgen Baylie
NWNuredin Chura Waritu
Nuredin Chura Waritu
Background: Overweight and obesity have arisen as major public health challenges, affecting not just the general population but also people living with human immunodeficiency virus (HIV) (PLWH). Obesity and being overweight are both risk factors for heart disease and other related complications. However, little is known in our setting. As a result, this study was conducted to evaluate the prevalence of overweight and obesity and its associated factors among PLWH on dolutegravir (DTG)‐ and efavirenz (EFV)‐based therapies.Methods: An institution‐based comparative cross‐sectional study was carried out from June 30, 2021, to August 30, 2021. We purposively recruited 128 participants who have been on DTG (n = 64)‐ and EFV (n = 64)‐based regimens for ≥ 6 months. Demographic, anthropometric, laboratory, and clinical data were collected using a structured questionnaire. The data were entered into EpiData Version 4.6 and analyzed using SPSS Version 26.0. Multivariable logistic regression was utilized to identify the factors that are associated with being overweight or obese, and the significance level was set at p < 0.05.Result: The prevalence of overweight and obesity was 28.1% in the DTG‐prescribed participants and 15.6% in the EFV‐prescribed participants. Age ≥ 40 years (adjusted odd ratio (AOR) = 3.86; 95% confidence interval (CI): 1.08–13.73; and p = 0.037), cluster of differentiation 4 (CD4) T‐cell counts ≥ 500 cells/mm3 (AOR = 2.95; 95% CI: 1.01–8.59; and p = 0.029), and insufficient physical activity (AOR = 4.6; 95% CI: 1.53–13.84; and p = 0.007) were predictors of overweight and obesity.Conclusion: Overweight and obesity are not uncommon among PLWH on ART. While the difference was statistically insignificant, the prevalence of overweight and obesity was higher in patients treated with DTG compared with those treated with EFV. Older age, higher CD4 cell counts, and insufficient physical activity were associated with overweight and obesity. As a result, healthcare providers must understand the health implications of obesity and consider incorporating targeted weight control programs into standard HIV treatment.